Evidence map›Paper›PMID 28297566›Full record

ArticleStem cells translational medicine2017

Instructive Role of the Microenvironment in Preventing Renal Fibrosis.

Kei Matsumoto, Sandhya Xavier, Jun Chen, Yujiro Kida, Mark Lipphardt, Reina Ikeda, Annie Gevertz, Mario Caviris, Antonis K Hatzopoulos, Ivo Kalajzic and 6 more

Open access · goldAbstract read
In one paragraph

Article in Stem cells translational medicine, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
1.6field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 23 citations in OpenAlex.

  1. Review
  2. Permissive role of vascular endothelium in fibrosis: focus on the kidney.American journal of physiology. Cell physiology · 2024
    Review
  3. Role of Interleukin-6 Family Cytokines in Organ Fibrosis.Kidney diseases (Basel, Switzerland) · 2023
    Review
  4. Review
  5. Roles of mesenchymal stromal cells in the head and neck cancer microenvironment.Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie · 2021
    Review
  6. Role of protein phosphatase 2A in kidney disease (Review).Experimental and therapeutic medicine · 2021
    Review
  7. New Trends in Regenerative Medicine: Reprogramming and Reconditioning.Journal of the American Society of Nephrology : JASN · 2019
    Article
  8. Article
  9. Dickkopf-3 in aberrant endothelial secretome triggers renal fibroblast activation and endothelial-mesenchymal transition.Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association · 2019
    Article
  10. Article
  11. Review
  12. Article
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors at 6 institutions in 4 countries.

Kei MatsumotoDepartment of Medicine, New York Medical College, Valhalla, New York, USA.
Sandhya XavierDepartment of Medicine, New York Medical College, Valhalla, New York, USA.
Jun ChenDepartment of Medicine, New York Medical College, Valhalla, New York, USA.
Yujiro KidaDepartment of Medicine, New York Medical College, Valhalla, New York, USA.
Mark LipphardtDepartment of Medicine, New York Medical College, Valhalla, New York, USA.
Reina IkedaDepartment of Medicine, New York Medical College, Valhalla, New York, USA.
Annie GevertzDepartment of Medicine, New York Medical College, Valhalla, New York, USA.
Mario CavirisDepartment of Medicine, New York Medical College, Valhalla, New York, USA.
Antonis K HatzopoulosVanderbilt University, Nashville, Tennessee, USA.
Ivo KalajzicUniversity of Connecticut Health Center, Farmington, Connecticut, USA.
James DuttonStem Cell Institute, University of Minnesota, Minneapolis, Minnesota, USA.
Brian B RatliffDepartment of Medicine, New York Medical College, Valhalla, New York, USA.
Hong ZhaoDepartment of Medicine, New York Medical College, Valhalla, New York, USA.
Zbygniew DarzynkiewiczDepartment of Medicine, New York Medical College, Valhalla, New York, USA.
Stefan Rose-JohnInstitute of Biochemistry, Christian-Albrechts University, Kiel, Germany.
Michael S GoligorskyDepartment of Medicine, New York Medical College, Valhalla, New York, USA.
New York Medical College · USKiel University · DEOkayama University · JPUConn Health · USUniversity of Minnesota · USVanderbilt Health · US

Funding

Notch Signaling and Bone Fracture HealingR01AR055607 · NIAMS · UNIVERSITY OF CONNECTICUT SCH OF MED/DNT · PI Kurt David Hankenson, IVO Kalajzic · 2011 to 2026
$6.3M
RENAL ENDOTHELIAL AND SMOOTH MUSCLE CELLS INTERACTIONSR01DK045462 · NIDDK · STATE UNIVERSITY NEW YORK STONY BROOK · PI GOLIGORSKY, MICHAEL S · 1995 to 2014
$4.8M
VASCULAR PERMEABILITY IN DIABETIC NEPHROPATHYR01DK054602 · NIDDK · STATE UNIVERSITY NEW YORK STONY BROOK · PI GOLIGORSKY, MICHAEL S · 1999 to 2010
$2.5M
Endothelial dysfunction in acute renal ischemiaR01DK052783 · NIDDK · STATE UNIVERSITY NEW YORK STONY BROOK · PI GOLIGORSKY, MICHAEL S · 1997 to 2007
$2.0M
NIAMS NIH HHS R01 AR055607NIDDK NIH HHS R01 DK045462NIDDK NIH HHS R01 DK052783NIDDK NIH HHS R01 DK054602
6 · The paper itself

Abstract

Accumulation of myofibroblasts is a hallmark of renal fibrosis. A significant proportion of myofibroblasts has been reported to originate via endothelial-mesenchymal transition. We initially hypothesized that exposing myofibroblasts to the extract of endothelial progenitor cells (EPCs) could reverse this transition. Indeed, in vitro treatment of transforming growth factor-β1 (TGF-β1)-activated fibroblasts with EPC extract prevented expression of α-smooth muscle actin (α-SMA); however, it did not enhance expression of endothelial markers. In two distinct models of renal fibrosis-unilateral ureteral obstruction and chronic phase of folic acid-induced nephropathy-subcapsular injection of EPC extract to the kidney prevented and reversed accumulation of α-SMA-positive myofibroblasts and reduced fibrosis. Screening the composition of EPC extract for cytokines revealed that it is enriched in leukemia inhibitory factor (LIF) and vascular endothelial growth factor. Only LIF was capable of reducing fibroblast-to-myofibroblast transition of TGF-β1-activated fibroblasts. In vivo subcapsular administration of LIF reduced the number of myofibroblasts and improved the density of peritubular capillaries; however, it did not reduce the degree of fibrosis. A receptor-independent ligand for the gp130/STAT3 pathway, hyper-interleukin-6 (hyper-IL-6), not only induced a robust downstream increase in pluripotency factors Nanog and c-Myc but also exhibited a powerful antifibrotic effect. In conclusion, EPC extract prevented and reversed fibroblast-to-myofibroblast transition and renal fibrosis. The component of EPC extract, LIF, was capable of preventing development of the contractile phenotype of activated fibroblasts but did not eliminate TGF-β1-induced collagen synthesis in cultured fibroblasts and models of renal fibrosis, whereas a receptor-independent gp130/STAT3 agonist, hyper-IL-6, prevented fibrosis. In summary, these studies, through the evolution from EPC extract to LIF and then to hyper-IL-6, demonstrate the instructive role of microenvironmental cues and may provide in the future a facile strategy to prevent and reverse renal fibrosis. Stem Cells Translational Medicine 2017;6:992-1005.

Indexed as

Cellular Microenvironment3T3 CellsAnimalsChemokinesCytokine Receptor gp130Endothelial Progenitor CellsFibroblastsFibrosisInterleukin-6KidneyLeukemia Inhibitory FactorMiceMice, Inbred C57BLMice, TransgenicMyofibroblastsPhosphorylationChemokinesCytokine Receptor gp130Interleukin-6Leukemia Inhibitory FactorSTAT3 Transcription FactorTranscription FactorsGreen fluorescent proteinHyper-interleukin-6Leukemia inhibitory factorTransforming growth factor-β1α-Smooth muscle actin

Identifiers

PMID28297566
PMCPMC5442777
OpenAlexW2527963201

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.